VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1577502
Sex: U
Age:
State:

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: DISCOMFORT; TIREDNESS; FEELING MILD NAUSEA; HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On APR-2021, the patient experienced discomfort. On APR-2021, the patient experienced tiredness. On APR-2021, the patient experienced feeling mild nausea. On APR-2021, the patient experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from discomfort, tiredness, feeling mild nausea, and headache on APR-2021. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577503
Sex: U
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: INFLAMMATION IN VARIOUS MUSCLES; INFLAMMATION IN TENDONS; INFLAMMATION IN JOINTS/INFLAMMATION MOVING AREA TO AREA; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced inflammation in various muscles, inflammation in tendons, and inflammation in joints/inflammation moving area to area. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from inflammation in various muscles, inflammation in tendons, and inflammation in joints/inflammation moving area to area. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577504
Sex: F
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: SYMPTOMS/UNSPECIFIED ADVERSE EVENT; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced symptoms/unspecified adverse event. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of symptoms/unspecified adverse event was not reported. This report was non-serious. This case, from the same reporter is linked to 20210826468.

Other Meds:

Current Illness:

ID: 1577505
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: SORE ARM; FATIGUE; SLIGHT FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced sore arm, fatigue, and slight fever. The action taken with covid-19 vaccine was not applicable. The outcome of the sore arm, fatigue and slight fever was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577506
Sex: M
Age:
State: CA

Vax Date:
Onset Date: 08/11/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: BRUISES ON MIDDLE OF FOREHEAD, EYEBROWS AND LEFT EYE WHICH HURTS; This spontaneous report received from a consumer concerned a 26 year old male. The patient's weight was 180 pounds, and height was 75 inches. The patient's concurrent conditions included: smoker, non-alcohol user, and bipolar, and other pre-existing medical conditions included: The patient had no known allergies. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 1808982, and expiry: UNKNOWN) dose was not reported, administered on 09-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-AUG-2021, the patient experienced bruises on middle of forehead, eyebrows and left eye which hurts. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from bruises on middle of forehead, eyebrows and left eye which hurts. This report was non-serious.

Other Meds:

Current Illness: Abstains from alcohol; Bipolar disorder; Smoker (Smokes marihuana once a day)

ID: 1577507
Sex: F
Age:
State: ME

Vax Date:
Onset Date: 08/12/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: VACCINATION FROM VIAL THAT WAS PUNCTURED LONGER THAN 6 HOURS (25 HOURS); VIAL WAS KEPT IN REFRIGERATOR FOR MORE THAN 6 HOURS AFTER PUNCTURE; This spontaneous report received from a health care professional concerned a 66 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 1808982 and expiry: 21-SEP-2021) dose was not reported, administered on 12-AUG-2021 13:00 for prophylactic vaccination. No concomitant medications were reported. On 12-AUG-2021, the patient experienced vaccination from vial that was punctured longer than 6 hours (25 hours). On 12-AUG-2021, the patient experienced vial was kept in refrigerator for more than 6 hours after puncture. The action taken with covid-19 vaccine was not applicable. The outcome of the vaccination from vial that was punctured longer than 6 hours (25 hours) and vial was kept in refrigerator for more than 6 hours after puncture was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577508
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: FELT A BIT WARM; HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included: covid-19. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced felt a bit warm, and headache. The action taken with covid-19 vaccine was not applicable. The outcome of the headache and felt a bit warm was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577509
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: RHABDOMYOLYSIS; This spontaneous report received from a patient of unspecified age and sex with unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry date were not reported) dose was not reported, 1 total, administered on 17-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. About 2 weeks later after vaccination patient had really bad cramps and spasms all over body 4 to 5 times a day. On 12-JUL-2021 patient went to hospital for having cramps like an heart attack. But did not had heart attack. Patient was said it was rhabdomyolysis. Patient had given intravenous fluids. But was still having them in legs, arms butt chest growing area calfs side and back. Pain lasted about 30 mins each time. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from rhabdomyolysis. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0 20210826860-covid-19 vaccine ad26.cov2.s-Rhabdomyolysis. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Other Meds:

Current Illness:

ID: 1577510
Sex: F
Age:
State: OH

Vax Date:
Onset Date: 07/31/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: LOW BLOOD PRESSURE; STOMACH HURTING; DIZZINESS; LETHARGY; NOT EATING WELL; NO APPETITE; DIARRHEA; WEAK; HIGH TEMPERATURE OF 102.1; This spontaneous report received from a consumer concerned a 64 year old female. The patient's height, and weight were not reported. The patient's past medical history included: lung surgery, hernia surgery, tied tubes, and back surgery, and concurrent conditions included: peripheral artery disease, lung cancer, and seasonal allergy, and other pre-existing medical conditions included: Patient had Imder allergy. The patient experienced drug allergy when treated with clotrimazole, oxycodone hydrochloride/paracetamol, and simvastatin. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 31-JUL-2021, the patient experienced low blood pressure. On 31-JUL-2021, the patient experienced stomach hurting. On 31-JUL-2021, the patient experienced dizziness. On 31-JUL-2021, the patient experienced lethargy. On 31-JUL-2021, the patient experienced not eating well. On 31-JUL-2021, the patient experienced no appetite. On 31-JUL-2021, the patient experienced diarrhea. On 31-JUL-2021, the patient experienced weak. On 31-JUL-2021, the patient experienced high temperature of 102.1. Laboratory data included: Body temperature (NR: not provided) 102.1. The action taken with covid-19 vaccine was not applicable. The outcome of the diarrhea, stomach hurting, low blood pressure, high temperature of 102.1, dizziness, lethargy, not eating well, weak and no appetite was not reported. This report was non-serious. This case, involving the same patient is linked to 20210826468.

Other Meds:

Current Illness: Lung cancer; Peripheral arterial disease; Seasonal allergy

ID: 1577511
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: EXTREME BODY ACHES; COULD NOT GET OUT OF BED FOR A FULL DAY; FEVER; NAUSEA; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included: covid-19. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced extreme body aches, could not get out of bed for a full day, fever, and nausea. The action taken with covid-19 vaccine was not applicable. The patient recovered from extreme body aches, could not get out of bed for a full day, fever, and nausea. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577512
Sex: F
Age:
State: OH

Vax Date:
Onset Date: 08/13/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: LUMP IN UPPER RIGHT LEG; This spontaneous report received from a patient concerned a 53 year old female. The patient's height, and weight were not reported. The patient's past medical history included: toxemia when pregnant. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 1821281 expiry: UNKNOWN) dose was not reported, administered on 03-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-AUG-2021, the patient experienced lump in upper right leg. The action taken with covid-19 vaccine was not applicable. The outcome of lump in upper right leg was not reported. This report was non-serious. This case is associated with Product Quality Complaint number: 90000189496

Other Meds:

Current Illness:

ID: 1577513
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: BLACKED OUT UNCONSCIOUS IMMEDIATELY AFTER THE SHOT; SHOOTING PAIN IN HEART; This spontaneous report received from a patient via social media via a company representative concerned a 38 year old female. The patient's height, and weight were not reported. Patient was healthy. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported,1 total, therapy start date was not reported for prophylactic vaccination. Batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient was blacked out unconscious immediately after the vaccination with shooting pain in heart. Patient was taken to the emergency room. Patient had elevated troponin levels. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the blacked out unconscious immediately after the shot and shooting pain in heart was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210827757-covid-19 vaccine ad26.cov2.s-blacked out unconscious immediately after the shot and shooting pain in heart. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Other Meds:

Current Illness:

ID: 1577514
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: CHILLS; HEADACHES; EXTREME EXHAUSTION; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced chills, headaches, and extreme exhaustion. The action taken with covid-19 vaccine was not applicable. The patient recovered from chills, headaches, and extreme exhaustion. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577515
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: BURNING SENSATION ALL OVER BODY; NEEDLE AND PIN PAIN ALL OVER; NUMB AFTER JJ JAB; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced burning sensation all over body, needle and pin pain all over, and numb after jj jab. The action taken with covid-19 vaccine was not applicable. The outcome of the numb after jj jab, burning sensation all over body and needle and pin pain all over was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577516
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: GASTROINTESTINAL SYMPTOMS; FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced gastrointestinal symptoms, and fever. The action taken with covid-19 vaccine was not applicable. The outcome of the fever and gastrointestinal symptoms was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577517
Sex: M
Age:
State: GA

Vax Date:
Onset Date: 05/07/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: LITTLE SWOLLEN LEFT KNEE; CALF HURTING ON AND OFF; TINGLING IN BOTH FEET; WEAK PAINFUL LEGS; PAIN WORST IN THE LEFT LEG, LITTLE PAIN IN THE RIGHT LEG WHICH COMES BACK AND FORTH IN THE LAST COUPLE OF WEEKS BUT NOT AS THE LEFT LEG; PAIN MOVING UP FROM THE HIP TO CLOSE TO THE LEFT SIDE OF THE LOWER MIDDLE OF THE BACK, MOST PAIN WAS IN THE LEFT SIDE OF THE BACK; HEART RACING; PAIN IN RIGHT HIP WHICH WENT AWAY (DID NOT HURT ANYMORE) AND SWITCHED TO LEFT HIP AND WENT DOWN TO BOTH LEGS; LIGHT-HEADED; LOWER SPINE STARTED TO HURT WHICH WAS INITIATED BY THE SCIATIC NERVE AREA ON THE RIGHT HIP; This spontaneous report received from a patient concerned a 63 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 206A21A, expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-MAY-2021, the patient experienced lower spine started to hurt which was initiated by the sciatic nerve area on the right hip. On 14-MAY-2021, the patient experienced light-headed. On 05-JUN-2021, the patient experienced pain in right hip which went away (did not hurt anymore) and switched to left hip and went down to both legs. On 13-JUL-2021, the patient experienced heart racing. On 30-JUL-2021, the patient experienced pain moving up from the hip to close to the left side of the lower middle of the back, most pain was in the left side of the back. On 13-AUG-2021, the patient experienced pain worst in the left leg, little pain in the right leg which comes back and forth in the last couple of weeks but not as the left leg. On an unspecified date, the patient experienced little swollen left knee, calf hurting on and off, tingling in both feet, and weak painful legs. Laboratory data (dates unspecified) included: X-ray (NR: not provided) Spine looked fine. Treatment medications (dates unspecified) included: cyclobenzaprine hydrochloride. The action taken with covid-19 vaccine was not applicable. The patient recovered from lower spine started to hurt which was initiated by the sciatic nerve area on the right hip on 05-JUN-2021, had not recovered from pain in right hip which went away (did not hurt anymore) and switched to left hip and went down to both legs, pain moving up from the hip to close to the left side of the lower middle of the back, most pain was in the left side of the back, heart racing, and pain worst in the left leg, little pain in the right leg which comes back and forth in the last couple of weeks but not as the left leg, and the outcome of little swollen left knee, calf hurting on and off, light-headed, tingling in both feet and weak painful legs was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577518
Sex: F
Age:
State: CA

Vax Date:
Onset Date: 07/29/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: LOSS OF APPETITE; SLIGHT CHILLS; TENDERNESS AT SITE OF INJECTION; FATIGUE; SEVERE MUSCLE ACHE; This spontaneous report received from a patient concerned a 38 year old female. The patient's weight was 117 pounds, and height was 67 inches. The patient's concurrent conditions included: non-alcohol user, non-smoker, allergy to lotion, and allergy to gum. The patient had no history of drug abuse or illicit drug use and no allergy to any medication. The patient experienced drug allergy when treated with dimeticone for drug used for unknown indication. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 204B214, and expiry: UNKNOWN) dose was not reported, administered on 29-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 29-JUL-2021, the patient experienced loss of appetite. On 29-JUL-2021, the patient experienced slight chills. On 29-JUL-2021, the patient experienced tenderness at site of injection. On 29-JUL-2021, the patient experienced fatigue. On 29-JUL-2021, the patient experienced severe muscle ache. The action taken with covid-19 vaccine was not applicable. The outcome of the tenderness at site of injection, fatigue, severe muscle ache, slight chills and loss of appetite was not reported. This report was non-serious.

Other Meds:

Current Illness: Abstains from alcohol; Allergy; Food allergy; Non-smoker

ID: 1577519
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: BODY ACHES; HAD A VERY STRONG IMMUNE RESPONSE; CHILLS; 103 DEG FEVER FOR MORE THAN 8 HOURS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included: covid, and sniffles. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced body aches, had a very strong immune response, chills, and 103 deg fever for more than 8 hours. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 103 degree. The action taken with covid-19 vaccine was not applicable. The outcome of the body aches, chills, 103 deg fever for more than 8 hours and had a very strong immune response was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577520
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: SEVERE REACTION; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAY-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced severe reaction. The action taken with covid-19 vaccine was not applicable. The outcome of severe reaction was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577521
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: MILD HEADACHE; MILD NAUSEA; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested .No concomitant medications were reported. On an unspecified date, the patient experienced mild headache, and mild nausea. The action taken with covid-19 vaccine was not applicable. The outcome of the mild headache and mild nausea was not reported. This report was non-serious. This case, from the same reporter is linked to 20210829201.

Other Meds:

Current Illness:

ID: 1577522
Sex: M
Age:
State: FL

Vax Date:
Onset Date: 08/12/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: RUNNY NOSE; SORE THROAT; HEADACHE; This spontaneous report received from a patient concerned a 31 year old male. The patient's weight was 250 pounds, and height was 69 inches. The patient's concurrent conditions included: non-smoker, and non alcohol user, and other pre-existing medical conditions included: The patient have No known allergies and no drug abuse or illicit drug usage. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, expiry: UNKNOWN) dose was not reported, administered on 19-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 12-AUG-2021, the patient experienced runny nose. On 12-AUG-2021, the patient experienced sore throat. On 12-AUG-2021, the patient experienced headache. The action taken with covid-19 vaccine was not applicable. The outcome of the runny nose, headache and sore throat was not reported. This report was non-serious.

Other Meds:

Current Illness: Abstains from alcohol; Non-smoker

ID: 1577523
Sex: M
Age:
State: TN

Vax Date:
Onset Date: 08/13/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: FEVER; This spontaneous report received from a patient concerned a 21 year old male. The patient's height, and weight were not reported. The patient's past medical history included: covid, and other pre-existing medical conditions included: The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: 21-SEP-2021) dose was not reported, administered on 12-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-AUG-2021, the patient experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577524
Sex: M
Age:
State: CA

Vax Date:
Onset Date: 08/13/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: MORE TIRED THAN USUAL; MUSCLE ACHES; This spontaneous report received from a patient concerned a 52 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: high blood pressure, and not able to drink milk, and other pre-existing medical conditions included: Patient had no known drug allergies. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 204A21A, and expiry: UNKNOWN) dose was not reported, administered on 12-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-AUG-2021, the patient experienced more tired than usual. On 13-AUG-2021, the patient experienced muscle aches. The action taken with covid-19 vaccine was not applicable. The outcome of the more tired than usual and muscle aches was not reported. This report was non-serious.

Other Meds:

Current Illness: Blood pressure high (that patient take medication)

ID: 1577525
Sex: F
Age:
State: CA

Vax Date:
Onset Date: 07/07/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: DIZZINESS; VOMITING; NAUSEA; ELEVATED BODY TEMPERATURE; METALLIC TASTE IN THE MOUTH; MIGRAINE HEADACHES; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: cold, and warm body, and other pre-existing medical conditions included: The patient had extreme sensitivity to all medications and supplements. The patient had not changed her diet nor was she exposed to anything. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 203A21A, expiry: UNKNOWN) dose was not reported, administered on 07-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On JUL-2021, Laboratory data included: Body temperature (NR: not provided) 98.4-98.8. On 07-JUL-2021, the patient experienced migraine headaches. On 07-JUL-2021, the patient experienced metallic taste in the mouth. On 07-JUL-2021, the patient experienced nausea. On 07-JUL-2021, the patient experienced elevated body temperature. Laboratory data included: Body temperature (NR: not provided) 98.8-99.2. On 08-JUL-2021, the patient experienced dizziness. On 08-JUL-2021, the patient experienced vomiting. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 97.4-97.8. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizziness, and vomiting on 11-JUL-2021, nausea on 10-JUL-2021, and elevated body temperature on 28-JUL-2021, had not recovered from migraine headaches, and the outcome of metallic taste in the mouth was not reported. This report was non-serious. This case, from the same reporter is linked to 20210829031.

Other Meds:

Current Illness: Cold; Feeling of warmth (The patient constantly feels warm, the normal body temperature is 97.4-97.8.)

ID: 1577526
Sex: F
Age:
State:

Vax Date:
Onset Date: 08/13/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: RASH; FEVER; This spontaneous report received from a consumer concerned a 26 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-AUG-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 13-AUG-2021, the patient experienced rash. On 13-AUG-2021, the patient experienced fever. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from rash, and fever. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577527
Sex: M
Age:
State: NJ

Vax Date:
Onset Date: 08/13/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: VACCINE WAS ADMINISTERED WHEN EXPIRED BY 45 MINUTES - 1 HOUR (PAST THE ALLOWED 6 HOURS AFTER FIRST PUNCTURE); This spontaneous report received from a pharmacist concerned a 39 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: No known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808986, expiry: 02-OCT-2021) dose was not reported, administered on 13-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-AUG-2021, the patient experienced vaccine was administered when expired by 45 minutes - 1 hour (past the allowed 6 hours after first puncture). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of vaccine was administered when expired by 45 minutes - 1 hour (past the allowed 6 hours after first puncture) was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577528
Sex: M
Age:
State: CA

Vax Date:
Onset Date: 08/13/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: LEG PAIN ON THE SIDE WHERE PATIENT RECEIVED THE VACCINE (LEFT SIDE); This spontaneous report received from a consumer concerned a 19 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 206A21A, expiry: UNKNOWN) dose was not reported, administered on 12-AUG-2021 16:00 for prophylactic vaccination. No concomitant medications were reported. On 13-AUG-2021, the patient experienced leg pain on the side where patient received the vaccine (left side). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from leg pain on the side where patient received the vaccine (left side). This report was non-serious.

Other Meds:

Current Illness:

ID: 1577529
Sex: F
Age:
State: WI

Vax Date:
Onset Date: 08/03/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: SHARP PAIN IN BACK; COUGH; SORE THROAT (THAT'S GETTING WORSE); NASAL IRRITATION; This spontaneous report received from a patient concerned a 33 year old female. The patient's weight was 200 pounds, and height was 64 inches. The patient's concurrent conditions included: anxiety, cigarette smoker, non-alcohol user, depression, and attention deficit hyperactivity disorder (adhd), and other pre-existing medical conditions included: The patient had no known allergies. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 203A21A, and expiry: UNKNOWN) dose was not reported, administered on 20-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 03-AUG-2021, the patient experienced sore throat (that's getting worse). On 03-AUG-2021, the patient experienced nasal irritation. On 05-AUG-2021, Laboratory data included: SARS-CoV-2 RT-PCR test (NR: not provided) Negative, and SARS-CoV-2 rapid diagnostic test (NR: not provided) Negative. On 06-AUG-2021, the patient experienced cough. On 10-AUG-2021, the patient experienced sharp pain in back. On 14-AUG-2021, Laboratory data included: Chest X-ray (NR: not provided) Normal, and SARS-CoV-2 rapid diagnostic test (NR: not provided) Negative. Laboratory data (dates unspecified) included: Mononucleosis heterophile test (NR: not provided) Negative. Treatment medications (dates unspecified) included: azithromycin. The action taken with covid-19 vaccine was not applicable. The patient was recovering from nasal irritation, and cough, and had not recovered from sore throat (that's getting worse), and sharp pain in back. This report was non-serious.

Other Meds:

Current Illness: Abstains from alcohol; Anxiety; Attention deficit hyperactivity disorder; Cigarette smoker (Half a packet a day); Depression

ID: 1577530
Sex: U
Age:
State:

Vax Date:
Onset Date: 08/14/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: CHILLS; FEVER; NAUSEA; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: It was unknown if the patient had drug abuse or illicit drug usage, consume alcohol and smoke. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 13-AUG-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 14-AUG-2021, the patient experienced chills. On 14-AUG-2021, the patient experienced fever. On 14-AUG-2021, the patient experienced nausea. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from fever, chills, and nausea. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577531
Sex: F
Age:
State: NY

Vax Date:
Onset Date: 08/11/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: FELT WARM; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 11-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 11-AUG-2021, the patient experienced felt warm. Treatment medications included: paracetamol. The action taken with covid-19 vaccine was not applicable. The outcome of felt warm was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577532
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: COUGHING AND HACKING STUFF UP; SWOLLEN LYMPH NODES; HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced coughing and hacking stuff up, swollen lymph nodes, and headache. Laboratory data (dates unspecified) included: COVID-19 PCR test (NR: not provided) not reported, and COVID-19 antigen test (NR: not provided) negative. The action taken with covid-19 vaccine was not applicable. The outcome of the coughing and hacking stuff up, headache and swollen lymph nodes was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1577533
Sex: F
Age:
State: TX

Vax Date:
Onset Date: 08/13/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: SORE ARM; INCREASED HEART RATE; SHORTNESS OF BREATH; DIZZINESS; This spontaneous report received from a patient concerned a 62 year old female. The patient's weight was 165 pounds, and height was 65 inches. The patient's concurrent conditions included: outdoor allergies, social alcohol drinker, and non-smoker. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 13-AUG-2021 11:00 for prophylactic vaccination. Concomitant medications included salbutamol. On 13-AUG-2021, the patient experienced increased heart rate. On 13-AUG-2021, the patient experienced shortness of breath. On 13-AUG-2021, the patient experienced dizziness. Laboratory data included: Heart rate (NR: not provided) 115 Beats per minute, 90 Beats per minute. On 14-AUG-2021, the patient experienced sore arm. Laboratory data (dates unspecified) included: Heart rate (NR: not provided) 62 Beats per minute (normal). The action taken with covid-19 vaccine was not applicable. The patient had not recovered from increased heart rate, shortness of breath, dizziness, and sore arm. This report was non-serious.

Other Meds: ALBUTEROL [SALBUTAMOL]

Current Illness: Multiple allergies; Non-smoker; Social alcohol drinker (1-2 drinks once a month)

ID: 1577534
Sex: F
Age:
State: OK

Vax Date:
Onset Date: 08/01/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: FEELING STRANGE; TINGLING FEET AND FINGERS/FEELING LIKE PINS AND NEEDLES; FEELING AS ALMOST LIKE ANTS GOING UNDER THE SKIN; This spontaneous report received from a patient concerned a 49 year old female. The patient's weight was 125 pounds, and height was 163 centimeters. The patient's concurrent conditions included: non-alcohol user, and non-smoker, and other pre-existing medical conditions included: The patient had no known allergies. The patient had no history of drug abuse or illicit drug use. Described herself as very healthy, and had not had a reaction to other shots. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 205A21A, expiry: 21-SEP-2021) dose was not reported, administered on 27-JUL-2021 for prophylactic vaccination. Concomitant medications included ascorbic acid, and ergocalciferol. On AUG-2021, the patient experienced feeling strange. On AUG-2021, the patient experienced tingling feet and fingers/feeling like pins and needles. On AUG-2021, the patient experienced feeling as almost like ants going under the skin. The action taken with covid-19 vaccine was not applicable. The outcome of the feeling strange, tingling feet and fingers/feeling like pins and needles and feeling as almost like ants going under the skin was not reported. This report was non-serious.

Other Meds: VITAMIN D [ERGOCALCIFEROL]; VITAMIN C [ASCORBIC ACID]

Current Illness: Abstains from alcohol; Non-smoker

ID: 1577535
Sex: F
Age: 82
State: CA

Vax Date: 01/19/2021
Onset Date: 01/22/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: thumb started to swell; A little sore; its soft; feel like fluid; This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL SWELLING (thumb started to swell), PAIN IN EXTREMITY (A little sore), SOFT TISSUE INJURY (its soft) and OEDEMA (feel like fluid) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. Concurrent medical conditions included Penicillin allergy. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), APIXABAN (ELIQUIS) and METOPROLOL for an unknown indication. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced SOFT TISSUE INJURY (its soft) and OEDEMA (feel like fluid). On an unknown date, the patient experienced PERIPHERAL SWELLING (thumb started to swell) and PAIN IN EXTREMITY (A little sore). At the time of the report, PERIPHERAL SWELLING (thumb started to swell), PAIN IN EXTREMITY (A little sore), SOFT TISSUE INJURY (its soft) and OEDEMA (feel like fluid) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Treatment medications were not provided by reporter.

Other Meds: Lipitor, Eliquis, Metoprolol

Current Illness: Penicillin allergy

ID: 1577536
Sex: F
Age: 38
State: CA

Vax Date: 01/16/2021
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site became itchy; Injection site became red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Injection site became itchy) and VACCINATION SITE ERYTHEMA (Injection site became red) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Injection site became itchy) and VACCINATION SITE ERYTHEMA (Injection site became red). At the time of the report, VACCINATION SITE PRURITUS (Injection site became itchy) and VACCINATION SITE ERYTHEMA (Injection site became red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1577537
Sex: F
Age: 70
State: GA

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swelling on stomach area; legs were achy too; achy joint; injection site was sensitivie to touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE IRRITATION (injection site was sensitivie to touch), SWELLING (swelling on stomach area), PAIN IN EXTREMITY (legs were achy too) and ARTHRALGIA (achy joint) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. No medical history was reported by the reporter. Concomitant products included DEXLANSOPRAZOLE (DEXILANT), ESTRADIOL (ESTRADIOL TRANSDERMAL), EZETIMIBE, GLIPIZIDE, SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]), METFORMIN, METOPROLOL, EVOLOCUMAB (REPATHA SURECLICK), OLMESARTAN MEDOXOMIL (BENICAR), VITAMIN D2 and GUAIFENESIN (MUCINEX) for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE IRRITATION (injection site was sensitivie to touch). On 22-Jan-2021, the patient experienced SWELLING (swelling on stomach area), PAIN IN EXTREMITY (legs were achy too) and ARTHRALGIA (achy joint). The patient was treated with FUROSEMIDE, POTASSIUM CHLORIDE (LASIX + K) for Swelling, at an unspecified dose and frequency. On 14-Jan-2021, VACCINATION SITE IRRITATION (injection site was sensitivie to touch) had resolved. At the time of the report, SWELLING (swelling on stomach area), PAIN IN EXTREMITY (legs were achy too) and ARTHRALGIA (achy joint) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: DEXILANT; ESTRADIOL TRANSDERMAL; EZETIMIBE; GLIPIZIDE; JANUVIA [SITAGLIPTIN PHOSPHATE]; METFORMIN; METOPROLOL; REPATHA SURECLICK; BENICAR; VITAMIN D2; MUCINEX

Current Illness:

ID: 1577538
Sex: M
Age:
State: TX

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The patient's past medical history included Myasthenia gravis (The patient has the history of Myasthenia Gravis.) since an unknown date and Type 2 diabetes mellitus (The patient has the history of Type 2 Diabetes Mellitus.) since an unknown date. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced CHILLS (chills). On 21-Jan-2021, CHILLS (chills) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided No treatment information provided

Other Meds:

Current Illness: Myasthenia gravis (The patient has the history of Myasthenia Gravis.); Type 2 diabetes mellitus (The patient has the history of Type 2 Diabetes Mellitus.)

ID: 1577539
Sex: F
Age:
State: CO

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain under her ribs in L side; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain under her ribs in L side) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (pain under her ribs in L side). At the time of the report, PAIN (pain under her ribs in L side) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications reported. No treatment information provided.

Other Meds:

Current Illness:

ID: 1577540
Sex: F
Age: 83
State: NY

Vax Date: 02/13/2021
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Muscular discomfort top of left hand; Diarrhea; Sleepiness; Muscle weakness on right arm; Minor headache; Tenderness at the injection site; Swelling at injection site; Soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE DISCOMFORT (Muscular discomfort top of left hand), DIARRHOEA (Diarrhea), SOMNOLENCE (Sleepiness), MUSCULAR WEAKNESS (muscle weakness on right arm) and HEADACHE (Minor headache) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE DISCOMFORT (Muscular discomfort top of left hand), DIARRHOEA (Diarrhea), SOMNOLENCE (Sleepiness), MUSCULAR WEAKNESS (muscle weakness on right arm), HEADACHE (Minor headache), VACCINATION SITE PAIN (Tenderness at the injection site), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE PAIN (Soreness at injection site). At the time of the report, MUSCLE DISCOMFORT (Muscular discomfort top of left hand), DIARRHOEA (Diarrhea), SOMNOLENCE (Sleepiness), MUSCULAR WEAKNESS (muscle weakness on right arm), HEADACHE (Minor headache), VACCINATION SITE PAIN (Tenderness at the injection site), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE PAIN (Soreness at injection site) had resolved. No concomitant medications reported. No treatment information provided. Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Additional information included new event details and outcome of the earlier reported events.

Other Meds:

Current Illness:

ID: 1577541
Sex: M
Age:
State: PA

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: body pain/soreness; chills; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body pain/soreness), CHILLS (chills) and FATIGUE (tiredness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN (body pain/soreness), CHILLS (chills) and FATIGUE (tiredness). At the time of the report, PAIN (body pain/soreness), CHILLS (chills) and FATIGUE (tiredness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant drugs were reported. No treatment medications were reported. Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Event onset date was provided.

Other Meds:

Current Illness:

ID: 1577542
Sex: F
Age:
State: FL

Vax Date: 02/18/2021
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: severe headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (severe headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (severe headache). At the time of the report, HEADACHE (severe headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1577543
Sex: F
Age: 75
State:

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: result of INR test change- reduce to 1.5 to 1.7; affect the thickness of blood; This spontaneous case was reported by a consumer and describes the occurrence of INTERNATIONAL NORMALISED RATIO DECREASED (result of INR test change- reduce to 1.5 to 1.7) and HYPERCOAGULATION (affect the thickness of blood) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included WARFARIN for Clot blood. On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced INTERNATIONAL NORMALISED RATIO DECREASED (result of INR test change- reduce to 1.5 to 1.7) and HYPERCOAGULATION (affect the thickness of blood). At the time of the report, INTERNATIONAL NORMALISED RATIO DECREASED (result of INR test change- reduce to 1.5 to 1.7) and HYPERCOAGULATION (affect the thickness of blood) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Feb-2021, International normalised ratio decreased: (Low) INR values reduced to 1.5 to 1.7. No treatment information was provided.

Other Meds: WARFARIN

Current Illness:

ID: 1577544
Sex: F
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hot to touch; fever; swelling at the injection site; injection site redness; edema; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE WARMTH (hot to touch), PYREXIA (fever), INJECTION SITE SWELLING (swelling at the injection site), INJECTION SITE ERYTHEMA (injection site redness) and OEDEMA (edema) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history Provided.). On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (hot to touch), PYREXIA (fever), INJECTION SITE SWELLING (swelling at the injection site), INJECTION SITE ERYTHEMA (injection site redness) and OEDEMA (edema). At the time of the report, VACCINATION SITE WARMTH (hot to touch), PYREXIA (fever), INJECTION SITE SWELLING (swelling at the injection site), INJECTION SITE ERYTHEMA (injection site redness) and OEDEMA (edema) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1577545
Sex: F
Age:
State: MA

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling under the eyes; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of EYE SWELLING (Swelling under the eyes) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse reaction. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EYE SWELLING (Swelling under the eyes). The patient was treated with HYALURONIC ACID (RESTYLANE) on 03-Oct-2020 at an unspecified dose and frequency. At the time of the report, EYE SWELLING (Swelling under the eyes) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1577546
Sex: F
Age: 82
State: NY

Vax Date: 01/11/2021
Onset Date: 01/16/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Redness; Itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE PRURITUS (Itchy) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Thyroid disorder (Patient is under medication for the same) and Cholesterol (Patient is under medication for the same). Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), THYROID and CHOLESTEROL for an unknown indication. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE PRURITUS (Itchy). At the time of the report, VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE PRURITUS (Itchy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; THYROID; CHOLESTEROL

Current Illness: Cholesterol (Patient is under medication for the same); Thyroid disorder (Patient is under medication for the same)

ID: 1577547
Sex: F
Age: 50
State: NC

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: A horrible headache as bad as a migraine, headache; Some aches and pains; Headache; This spontaneous case was reported by a nurse and describes the occurrence of MIGRAINE (A horrible headache as bad as a migraine, headache), PAIN (Some aches and pains) and HEADACHE (Headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 028L20A) for COVID-19 vaccination. The patient's past medical history included No adverse reaction. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced MIGRAINE (A horrible headache as bad as a migraine, headache), PAIN (Some aches and pains) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) for Pain, at an unspecified dose and frequency. On 22-Jan-2021, MIGRAINE (A horrible headache as bad as a migraine, headache), PAIN (Some aches and pains) and HEADACHE (Headache) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1577548
Sex: F
Age: 49
State: OR

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain; discomfort; swelling in neck on the right side; lymphadenopathy-multiple swollen lymph nodes on both sides of neck; Swollen arm; Red arm; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PAIN (pain), DISCOMFORT (discomfort), SWELLING (swelling in neck on the right side), VACCINATION SITE SWELLING (Swollen arm) and VACCINATION SITE ERYTHEMA (Red arm) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Tobacco user since an unknown date and Motor vehicle accident (Caused neck pain) on 29-Oct-2020. Concurrent medical conditions included Bipolar II disorder, Prediabetes, Anxiety, Hyperlipidemia and Drug allergy (Oxycodone and Chantix allergy.). Concomitant products included LAMOTRIGINE (LAMICTAL) for an unknown indication. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Swollen arm) and VACCINATION SITE ERYTHEMA (Red arm). On 16-Feb-2021, the patient experienced PAIN (pain), DISCOMFORT (discomfort), SWELLING (swelling in neck on the right side) and LYMPHADENOPATHY (lymphadenopathy-multiple swollen lymph nodes on both sides of neck). The patient was treated with PARACETAMOL (TYLENOL) for Lymphadenopathy, at an unspecified dose and frequency and IBUPROFEN SODIUM (IBUPROFEN [IBUPROFEN SODIUM]) for Lymphadenopathy, at an unspecified dose and frequency. At the time of the report, PAIN (pain), DISCOMFORT (discomfort), SWELLING (swelling in neck on the right side), VACCINATION SITE SWELLING (Swollen arm), VACCINATION SITE ERYTHEMA (Red arm) and LYMPHADENOPATHY (lymphadenopathy-multiple swollen lymph nodes on both sides of neck) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Feb-2021, Computerised tomogram: abnormal (abnormal) revealed multiple swollen lymph nodes on both sides of neck. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided.

Other Meds: LAMICTAL

Current Illness: Anxiety; Bipolar II disorder; Drug allergy (Oxycodone and Chantix allergy.); Hyperlipidemia; Prediabetes; Tobacco user

ID: 1577549
Sex: F
Age: 50
State: FL

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided. Treatment details included Tylenol. This case was linked to MOD-2021-016905, MOD-2021-016866 (Patient Link). This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Feb-2021 and was forwarded to Moderna on 18-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided. Treatment details included Tylenol. This case was linked to MOD-2021-016905, MOD-2021-016866 (Patient Link).

Other Meds:

Current Illness:

ID: 1577550
Sex: F
Age:
State:

Vax Date: 01/21/2021
Onset Date: 01/23/2021
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: left shoulder started hurting; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (left shoulder started hurting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Shoulder pain (left shoulder pain) since an unknown date. On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced ARTHRALGIA (left shoulder started hurting). At the time of the report, ARTHRALGIA (left shoulder started hurting) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided. No treatment details were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Jan-2021 and was forwarded to Moderna on 27-Jan-2021. This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (left shoulder started hurting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Shoulder pain (left shoulder pain) since an unknown date. On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced ARTHRALGIA (left shoulder started hurting). At the time of the report, ARTHRALGIA (left shoulder started hurting) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided. No treatment details were reported.

Other Meds:

Current Illness: Shoulder pain (left shoulder pain)

ID: 1577551
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 08/17/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: she got a delayed reaction below the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (she got a delayed reaction below the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. NO medical history information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (she got a delayed reaction below the injection site). At the time of the report, VACCINATION SITE RASH (she got a delayed reaction below the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment details were provided. Concomitant medication was not reported. Upon in internal review on 21 May 2021, the age was corrected to unknown age. This case was linked to MOD-2021-016747 (E2B Linked Report). This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Jan-2021 and was forwarded to Moderna on 27-Jan-2021. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (she got a delayed reaction below the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. NO medical history information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (she got a delayed reaction below the injection site). At the time of the report, VACCINATION SITE RASH (she got a delayed reaction below the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment details were provided. Concomitant medication was not reported. Upon in internal review on 21 May 2021, the age was corrected to unknown age. This case was linked to MOD-2021-016747 (E2B Linked Report).; Sender's Comments: MOD-2021-016747:1 reporter with 2 patients

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm